Hospice propelling growth for publicly traded home-based care companies

Hospice propelling growth for publicly traded home-based care companies 
Hospice News; by Jim Parker; 5/23/25
Hospice has emerged as a growth engine for publicly traded home-based care companies, several of which are on the hunt for acquisitions. Hospice has buoyed growth for several companies as they battle home health-related headwinds, including reimbursement pressures. Companies like VITAS Healthcare (NYSE: CHE), which only provide hospice and palliative care, also saw substantial growth. ... VITAS attributes the revenue growth to an 11.9% increase in days-of-care and a geographically weighted average Medicare reimbursement rate increase of approximately 3.2%. Hospice is also fueling growth at Addus Homecare (Nasdaq: ADUS). ... Similar trends exist for other publicly traded companies, including Aveanna Healthcare (Nasdaq: AVAH), Enhabit Inc. (NYSE: EHAB), The Pennant Group (Nasdaq: PNTG) and BrightSpring Health Services (Nasdaq: BTSG).